arXiv (All)
open access
A small HER2 reader for routine H&E slides: real-world deployment
computer-vision-and-pattern-recognitioni-2-6i-4-9j-3machine-learningquantitative-methodssoftware-engineering
HER2 status decides who receives HER2-targeted therapy. Pathologists score HER2 protein by immunohistochemistry (IHC); equivocal IHC 2+ tumours, their hardest calls, wait for in situ hybridisation (ISH). We built a HER2 reader for routine H&E slides, owned end to end, as a baseline for pathologists.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Accurate assessment of surgical HER2-low status based on core needle biopsy data of breast cancer.#1284617
- A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors#1464719
- A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer#855003
- A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors#862657
- HER2 and LA/mUC: A Multi-country Chart Review Cohort Study#868582
Record · ID 1533519
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive